Context Therapeutics Commercial Paper Liability (Quarterly) Trends

Context Therapeutics, Inc. (CNTX)

2.45 -0.03 (-1.21%) USD | NASDAQ | Feb 25, 14:24

View Commercial Paper Liability (Quarterly) for CNTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Imunon, Inc.	--